Clinical Trials Browser

Completed × Glioblastoma × urelumab × Clear all

NCT02658981 2023-10-06

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Gliosarcoma